These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 25545248)

  • 61. Mass spectrometric identification of peptide hormones in doping-control analysis.
    Thevis M; Schänzer W
    Analyst; 2007 Apr; 132(4):287-91. PubMed ID: 17554406
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Complementary stable carbon isotope ratio and amount of substance measurements in sports anti-doping.
    Cawley AT; George AV
    Drug Test Anal; 2012 Dec; 4(12):897-911. PubMed ID: 22791679
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The importance of reference materials in doping-control analysis.
    Mackay LG; Kazlauskas R
    Anal Bioanal Chem; 2011 Aug; 401(2):483-92. PubMed ID: 21562740
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Expanding analytical possibilities concerning the detection of stanozolol misuse by means of high resolution/high accuracy mass spectrometric detection of stanozolol glucuronides in human sports drug testing.
    Schänzer W; Guddat S; Thomas A; Opfermann G; Geyer H; Thevis M
    Drug Test Anal; 2013; 5(11-12):810-8. PubMed ID: 23873860
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Running ahead of doping: analytical advances and challenges faced by modern laboratories ahead of Rio 2016.
    Aquino Neto FR; Sarderla VF; Mirotti L; Pizzatti L
    Bioanalysis; 2016 Sep; 8(17):1753-6. PubMed ID: 27491844
    [No Abstract]   [Full Text] [Related]  

  • 66. Modern techniques for the determination of anabolic-androgenic steroid doping in the horse.
    McKinney AR
    Bioanalysis; 2009 Jul; 1(4):785-803. PubMed ID: 21083138
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Formoterol concentrations in blood and urine: the World Anti-Doping Agency 2012 regulations.
    Eibye K; Elers J; Pedersen L; Henninge J; Hemmersbach P; Dalhoff K; Backer V
    Med Sci Sports Exerc; 2013 Jan; 45(1):16-22. PubMed ID: 22843108
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The potential role of oral fluid in antidoping testing.
    Anizan S; Huestis MA
    Clin Chem; 2014 Feb; 60(2):307-22. PubMed ID: 24153253
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A synopsis of the adverse analytical and atypical findings between 2005 and 2011 from the Doping Control Laboratory of Athens in Greece.
    Kioukia-Fougia N; Fragkaki A; Kiousi P; Leontiou IP; Dimopoulou H; Tsivou M; Lyris E; Georgakopoulos C
    J Anal Toxicol; 2014; 38(1):16-23. PubMed ID: 24194481
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Applications of liquid chromatography-mass spectrometry in doping control.
    Politi L; Groppi A; Polettini A
    J Anal Toxicol; 2005; 29(1):1-14. PubMed ID: 15808007
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Hair testing for doping agents. What is known and what remains to do.
    Kintz P; Gheddar L; Ameline A; Arbouche N; Raul JS
    Drug Test Anal; 2020 Mar; 12(3):316-322. PubMed ID: 31943812
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Concerning the viewpoint; "An anti-doping sampling strategy utilizing the sewerage systems of sport villages".
    Harman C; Reid M; Thomas KV
    Environ Sci Technol; 2011 May; 45(10):4191; author reply 4192. PubMed ID: 21500825
    [No Abstract]   [Full Text] [Related]  

  • 73. [Research progresses of anabolic steroids analysis in doping control].
    Long Y; Wang D; Li K; Liu F
    Se Pu; 2008 Jul; 26(4):417-23. PubMed ID: 18959235
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A forensic perspective of the AFL investigation into peptides: an antidoping investigation case study.
    Harcourt PR; Marclay F; Clothier B
    Br J Sports Med; 2014 May; 48(10):810-3. PubMed ID: 24642697
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Treating the elite athlete: anti-doping information for the health professional.
    Tandon S; Bowers LD; Fedoruk MN
    Mo Med; 2015; 112(2):122-8. PubMed ID: 25958657
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Advances in equine anti-doping.
    Cawley A
    Drug Test Anal; 2017 Sep; 9(9):1282-1283. PubMed ID: 28631881
    [No Abstract]   [Full Text] [Related]  

  • 77. Current status of hyphenated mass spectrometry in studies of the metabolism of drugs of abuse, including doping agents.
    Meyer MR; Maurer HH
    Anal Bioanal Chem; 2012 Jan; 402(1):195-208. PubMed ID: 21866399
    [TBL] [Abstract][Full Text] [Related]  

  • 78. High-performance sport, marijuana, and cannabimimetics.
    Hilderbrand RL
    J Anal Toxicol; 2011 Nov; 35(9):624-37. PubMed ID: 22080902
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Urine analysis concerning xenon for doping control purposes.
    Thevis M; Piper T; Geyer H; Schaefer MS; Schneemann J; Kienbaum P; Schänzer W
    Rapid Commun Mass Spectrom; 2015 Jan; 29(1):61-6. PubMed ID: 25462364
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Banned substances and their incidence: A retrospective view of the national laboratory of prevention and doping control of Mexico.
    Mercado Soberanes K; Camacho Frías E; Rodríguez Balandrán L; Rodríguez Fermán ME; Mendoza Méndez N; Velasco-Bejarano B
    Adicciones; 2019 Jul; 31(3):201-211. PubMed ID: 30059594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.